Loading

JSM Bioinformatics, Genomics and Proteomics

Computational Analysis of Single Nucleotide Polymorphism (Snps) In Human MYC Gene

Research Article | Open Access | Volume 3 | Issue 1

  • 1. Department of Bioinformatics, Africa city of technology, Sudan
  • 2. Department of Bioinformatics, Ibn Sena University, Sudan
  • 3. Department of Bioinformatics, Omdurman Ahlia University, Sudan
  • 4. Department of Bioinformatics, Omdurman Islamic University, Sudan
  • 5. Department of Bioinformatics, Alribat hospital University, Sudan
+ Show More - Show Less
Corresponding Authors
Afra Abd Elhamid Fadlalla Elshaikh, Department of Bioinformatics, Africa city of technology, Sudan, Tel: 249129666986
ABSTRACT

Background: The proto-oncogene c-MYC encodes a transcription factor that regulates cell proliferation, growth, apoptosis microRNAs expression. Dysregulated expression or function of c-Myc is one of the most common abnormalities in human malignancy. The c-myc gene comprises three exons. Exon 1 contains two promoters and is non coding. Exons 2 and 3 encode the Myc protein with translation initiation at nucleotide 16 of exon. In this paper we focused on predicting the effects that can be imposed by single nucleotide polymorphisms that have been reported in MYC gene using Insilico approaches.

Material and Methods: MYC gene was investigated in NCBI database (http://www.ncbi.nlm.nih.gov/) and SNPs were analyzed by computational softwares. SNPs in the coding region (exonal SNPs) that are non-synonymous (nsSNP) were analyzed by (sift, polyphen, Imutant and PHD-snp) softwares, and SNPs at un-translated region at 3’ends (3’UTR) were analyzed to predict the effect on miRNA binding on these regions that may greatly associated with tumor progression [25]. The SNPs at un-traslated region at 5’ ends (5UTR) were analyzed too by SNPs Function prediction software

Result: We analyzed 5954 SNPs from NCBI ,647 of them found in Homo sapiens, 156 SNPs in coding non synonymous regions (missense), 101 synonymous, 42 3UTR and 47 5UTR. Only SNPs are present on coding region, 3UTR and 5UTR selected to analysis.

Conclusion: Four SNPs had high score with PSIC SD range (1-099) and TOLERANCE INDEX equal (0 - 0.009); rs200431478, rs114570780, rs150308400, rs137906262. There were predicted to change the protein stability but only rs150308400 was predicted to be disease related. in 3UTR there were only 11 functional SNPs predicted, rs185650723 and rs4645970 contain D allele which is derived allele that disrupts a conserved miRNA sit while rs35524866 SNP contain (C) allele which is can create a new microRNA site.

KEYWORDS

• Proto-oncogene
• Malignancy
• Insilico
• Synonymous

CITATION

Fadlalla Elshaikh AAE, Elmahdi Ahmed MT, Daf Alla TIM, Mogammed Elbasheer AS, Ahmed AA, et al. (2016) Computational Analysis of Single Nucleotide Polymorphism (Snps) In Human MYC Gene. J Bioinform, Genomics, Proteomics 1(3): 1011.

INTRODUCTION

Lymphomas are a group of diseases caused by malignant lymphocytes that accumulate in lymph nodes and cause the characteristic clinical features of lymphadenopathy. Occasionally, they may spill over into blood or infiltrate organs outside the lymphoid tissue [1]. Burkitt lymphoma, a subdivision of lymphoma, is particularly prevalent in young children in tropical Africa, accounting for 30%–50% of all childhood cancers in equatorial Africa, most frequently affect extranodal sites including the jaws, the abdomen, and endocrine organs [2]. The disease is heterogeneous and harbouring many genetic abnormalities including disruption of C-Myc gene.

The proto-oncogene c-MYC encodes a transcription factor that regulates cell proliferation, growth, apoptosis [3] microRNAs expression [4,5]. Also it can facilitate mRNA cap methylation and translation [6] and stimulates transcription of rRNA genes [7]. Dysregulated expression or function of c-Myc is one of the most common abnormalities in human malignancy [8]. The c-myc gene comprises three exons. Exon 1 contains two promoters and is non coding. Exons 2 and 3 encode the Myc protein with translation initiation at nucleotide 16 of exon 2 [9].

A defining feature of Burkitt lymphoma is activation of the MYC gene at 8q24 through translocation with one of three immunoglobulin loci, which introduces a transcriptional enhancer element. In 80% of cases, this involves the immunoglobulin heavy chain locus at 14q32, with the breakpoint in the class switch region. In 15%, the gene encoding the kappa light chain at 2p11 is involved; while in 5% the lambda light chain gene at 22q11 is translocated resulting in overproduction of MYC protein [10,11].

Given its pivotal above mentioned roles many studies have focused on studying myc extensively especially the translocation. Myc transcriptional activity is regulated by phosphorylation at Ser-62 followed by Thr-58, and subsequent proteasomal degradation after performing its function [12-16]. Mutations of Myc residues Thr-58 and Ser-62, prevalently found in Burkitt lymphoma, are associated with stabilized mutant protein. In this paper we focused on predicting the effects that can be imposed by single nucleotide polymorphisms that have been reported in myc gene using Insilico approaches to shed a light on effect of these polymorphisms as the MYC protein levels are critically regulated, and even relatively small increases can destabilize cell growth control.

MATERIALS AND METHODS

The critical step in this work was to select SNPs for analysis by computational softwares; the selection was prioritizing SNPs in the coding region (exonal SNPs) that are non-synonymous (nsSNP) and SNPs at un-translated region at 3’ends (3’UTR) to predict the effect on miRNA binding on these regions that may greatly associated with tumor progression [13]. The SNPs at un-traslated region at 5’ ends (5UTR) were analyzed too by SNPs Function prediction software. The SNPs and the related ensembles protein (ESNP) were obtained from the SNPs database (dbSNPs) for computational analysis from http://www.ncbi.nlm. nih.gov/snp/ and Uniprot database.

GeneMANIA

GeneMANIA (http://www.genemania.org) is a web interface that helps predicting the function of genes and gene sets. GeneMANIA finds other genes that are related to a set of input genes, using a very large set of functional association data. Association data include protein and genetic interactions, pathways, co-expression, co-localization and protein domain similarity. GeneMANIA can be used to find new members of a pathway or complex, find additional genes you may have missed in your screen or find new genes with a specific function, such as protein kinases. Your question is defined by the set of genes you input [17].

Sorting intolerant from tolerant (SIFT)

SIFT (http://siftdna.org/www/SIFT_dbSNP.html) predicts the tolerated and deleterious SNPs and identifies the impact of amino acid substitution on protein function and phenotype alterations, so that users can prioritize substitutions for further study. The main underlying principle of this program is that it generates alignments with a large number of homologous sequences, and assigns scores to each residue ranging from zero to one. The threshold intolerance score for SNPs is 0.05 or less [18,19].

PolyPhen

PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/) is an online bioinformatics program to automatically predict the consequence of an amino acid change on the structure and function of a protein. This prediction is based on a number of features comprising the sequence, phylogenetic and structural information characterizing the substitution. Basically, this program searches for 3D protein structures, multiple alignments of homologous sequences and amino acid contact information in several protein structure databases, then calculates position-specific independent count scores (PSIC) for each of the two variants, and then computes the PSIC scores difference between two variants. The higher a PSIC score difference, the higher the functional impact a particular amino acid substitution is likely to have. Prediction outcomes could be classified as benign, possibly damaging or probably damaging, according to the posterior probability intervals (0, 0.2), (0.2, 0.85) and (0.85, 1), respectively. nsSNPs that predicted to be intolerant by Sift has been submitted to Polyphen as protein sequence in FASTA format that obtained from UniproktB/Expasy after submitting the relevant ensemble protein (ESNP) there, then we entered position of mutation, native amino acid and the new substituent for both structural and functional predictions [20].

I-Mutant

I-Mutant version 3.0 (http://gpcr2.biocomp.unibo.it/cgi/ predictors/I-Mutant3.0/I-Mutant3.0.cgi) was used to predict the protein stability changes upon single-site mutations. I-Mutant basically can evaluate the stability change of a single site mutation starting from the protein structure or from the protein sequences [21].

Predictor of human deleterious single nucleotide polymorphisms (PHD-SNP)

PhD- SNP is a web-based tool available at (http://snps. biofold.org/phd-snp/phd-snp.html).It predicts whether the new phenotype derived from a nsSNP is a disease related or not (neutral). Protein sequence from uniprot is submitted to the program after providing position and the new amino acid residue [22].

Project HOPE

Project Have Our Protein Explained (HOPE; http://www. cmbi.ru.nl/hope/home) is an automatic mutant analysis server to study the insight structural features of native protein and the variant models. HOPE provides the 3D structural visualization of mutated proteins, and gives the results by using UniProt and DAS prediction servers. Input method of Project HOPE carries the protein sequence and selection of Mutant variants. HOPE server predicts the output in the form of structural variation between mutant and wild type residues [23]. We submitted a sequence and mutation only for those that predicted to be damaging by both SIFT and Polyphen (Double Positive) servers.

Raptorx

It is Web-based method for protein secondary structure prediction, (http://raptorx.uchicago.edu/). It based on tertiary structure modeling, alignment quality assessment and sophisticated probabilistic alignment sampling. raptorX delivers high-quality structural models for many targets and it takes 35 min to finish processing a sequence of 200 amino acids [24]. C-MYC Protein sequences of the most deletrious nsSNP were presented to raptorx server to get the model sequence as PDB file. After that Chimera program had been to visualize the PDB file.

Chimera

Chimera (http://www.cgl.ucsf.edu/chimera) is a high-quality extensible program for interactive conception and analysis of molecular assemblies and related data [25]. This software produced by University of California, San Francisco (UCSF). Chimera (version 1.6.2) was used to generate the mutated 3D model models of each C-Myc protein [26].

PolymiRTS

(http://compbio.uthsc.edu/miRSNP/) is the database server designed specifically for the analysis of the 3’UTR region; at this stage we used this server to determine SNPs that may alter miRNA target sites. All SNPs located within the 3′-UTRs of database were selected separately and submitted to the program. Then we checked if the SNP variants could alter putative miRNA target sites focusing on mutations that alter sequence complementarity to miRNA seed regions [27].

SNP Function Prediction

(https://snpinfo.niehs.nih.gov/snpinfo/snpfunc.htm) It Is software designed to be a clearing house for all public domain SNP functional annotation data, as well as in-house functional annotations derived from different data sources. It currently contains SNP functional annotations in six major categories including genomic elements, transcription regulation, protein function, pathway, disease and population genetics [28].

RESULTS AND DISCUSSION

MYC gene has a vital role in human body and it is co-expressed with 14 genes listed in Table (1) and shared domain with only one gene (MAX) gene (Figure 1).

Show genes co- expression with C-MYC gene.

Figure 1: Show genes co- expression with C-MYC gene.

MYC gene was investigated in NCBI database (http://www.ncbi.nlm.nih.gov/). It contains a total of 5954 SNPs and 647 of which on Homo sapiens, 156 coding non synonymous regions (missense), 101 synonymous, 42 3UTR and 47 5UTR. Only SNPs are present on coding region, 3UTR and 5UTR selected to analysis. Non synonymous SNPs were analyzed by SIFT software, out of 29 SNPs only 15 SNPs were predicted to be deleterious. These deleterious SNPs were analyzed using PolyPhen software to predict the damaging SNPs, we found that 10 SNPs were predicted to be deleterious in both softwares. Four SNPs had high score with PSIC SD range (1- 099) and TOLERANCE INDEX equal (0 - 0.009); rs200431478, rs114570780, rs150308400, rs137906262 Table (3), Figure (2).

Show SNPs of human c-Myc1 protein predicted by SIFT, PolyPhen, Imutant and PHD-snp.

Figure 2: Show SNPs of human c-Myc1 protein predicted by SIFT, PolyPhen, Imutant and PHD-snp.

The same result was predicted by Mamoona Noreen et. al in 2015 [29].The rs200431478 result in substitution of a serine into a bigger and more hydrophobic phenylalanine at position (362 and 361) causing bumps and loss of hydrogen bonds, change of secondary structure, slight conformation destabilized and disturb correct folding and phosphorylation modification sit according to project hope software. The rs150308400 caused conversion of amino acid cysteine with a bigger and less hydrophobic tyrosine at position (148, 133 and 147) leading to bumps and loss of hydrophobic interactions and it was predicted to be disease related by PHD-snp software. These two SNPs were predicted to increase effective stability of protein using I mutant software Figure (3).

3D model by Chimera for MYC protein.

Figure 3: 3D model by Chimera for MYC protein.

The rs114570780 result in replacement of a tyrosine with a histidine at position (47, 46 and 32) which lead to loss of interactions, loss of hydrophobic interactions and disturbance the site of modification owing to histidine is smaller, less hydrophobic and not provide phosphorylation site according to Project hope software. This SNP was predicted to decrease effective stability of protein by I mutant software (Figure 3). The was no difference between the two amino acid in the fourth SNP rs137906262, leucine into isoleucine at position 158, but the mutant residue might disturb Sequence-Specific DNA Binding Transcription Factor Activity according to project hope software. This SNP also was predicted to decrease effective stability of protein by I mutant software (Figure 3). Functional SNPs in 3 untranslated region in MYC gene was analyzed using PollymiRTS software. Among 42 SNPs in 3UTR there were only 11 functional SNPs predicted. Rs 185650723 SNP contain (D) allele have (4) miRNA Site and rs4645970 SNP contain (D) allele have (4) miRNA Site which they are derived allele that disrupts a conserved miRNA sit. Rs35524866 SNP contain (C) allele have 5 miRNA Site as Target binding site can create a new microRNA site Table (4).

Table 1: shows the genes co-expressed and share a domain with C-MYC.

Gene Symbol                   Description CO-EX-PRESSION Shared domain
MAX MYC associated factor X NO Yes
BCAT1 branched chain amino-acid transaminase 1, cytosolic NO NO
DDX18 DEAD (Asp-Glu-Ala-Asp) box polypeptide 18 YES NO
MINA MYC induced nuclear antigen YES NO
CDR2 cerebellar degeneration-related protein 2, YES NO
EIF4E eukaryotic translation initiation factor 4E YES NO
ETV3 ets variant 3 NO NO
ZBTB17 zinc finger and BTB domain containing 17 YES NO
CSTB cystatin B (stefin B) YES NO
PTMA prothymosin, alpha NO NO
TFAP2C transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) NO NO
ATF2 activating transcription factor 2 YES NO
NMI N-myc (and STAT) interactor YES NO
CSDE1 cold shock domain containing E1, RNA-binding YES NO
TRRAP transformation/transcription domain-associated protein YES NO
CAD carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase YES NO
RCC1 regulator of chromosome condensation 1 YES NO
TAF12 TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa YES NO
TADA2A transcriptional adaptor 2A YES NO
CCNT1 cyclin T1 NO NO

Table 2: shows the C-MYC functions and its appearance in network and genome.

Feature FDR    Genes in network Genes in genome
internal peptidyl-lysine acetylation 1.98E-02     4 102
SAGA-type complex 1.98E-02    3 27
histone acetylation 1.98E-02    4 101
internal protein amino acid acetylation 1.98E-02    4 108
peptidyl-lysine acetylation 1.98E-02    4 106
protein acetylation 2.60E-02    4 121
histone acetyl transferase activity 2.94E-02    3 40
peptidyl-lysine modification 3.28E-02    4 138
protein acylation 3.64E-02    4 146
N-acetyltransferase activity 4.84E-02    3 53
N-acyltransferase activity 5.48E-02    3 57
acetyltransferase activity 6.47E-02    3 62
histone acetyltransferase complex 8.23E-02    3 69
STAGA complex 9.28E-02    2 12
protein acetyltransferase complex 9.28E-02    3 77
acetyltransferase complex 9.28E-02    3 77
FDR: False discovery rate is greater than or equal to the probability that this is a false positive

Table 3: shows of nonsynonymous SNPs predicted with SIFT, Polyphen, I-Mutant and PHD-snp programs, chosen SNPs with PSIC SD range (1-099) and TOLERANCE INDEX equal (0.009).

                                I mutant PHD-SNP
SNP PROTEIN ID REF ALLELE ALT ALLELE AMINO ACID CHANGE SIFT PREDICTION SIFT SCORE polyphen prediction polyphen score SVM2 Prediction Effect DDG Value Prediction RI effect RI
rs200431478 ENSP00000367207   C   T S362F DELETERIOUS 0.003 probably damaging 0.998 Increase -0.09 5 Neutral 5
rs200431478 ENSP00000430235   C   T S361F DELETERIOUS 0.003 probably damaging 0.998 Increase -0.09 5 Neutral 5
rs114570780 ENSP00000259523   T   C Y32H DELETERIOUS     0 probably damaging 0.999 Decrease -0.63 1 Neutral 6
rs114570780 ENSP00000367207   T   C Y47H DELETERIOUS     0 probably damaging 0.996 Decrease -0.63 1 Neutral 6
rs114570780 ENSP00000430235   T   C Y46H DELETERIOUS     0 probably damaging     1 Decrease -0.63 1 Neutral 6
rs150308400 ENSP00000259523   G   A C133Y DELETERIOUS     0 probably damaging 0.996 Increase -0.23 1 Disease 9
rs150308400 ENSP00000367207   G   A C148Y DELETERIOUS     0 probably damaging 0.991 Increase -0.23 1 Disease 9
rs150308400 ENSP00000429441   G   A C147Y DELETERIOUS     0 probably damaging 0.999 Increase -0.23 1 Disease 9
rs137906262 ENSP00000429441   C   A L158I DELETERIOUS 0.009 possibly damaging 0.933 Decrease   -1 6 Neutral 2

Table 4: shows the SNPs predicted by Polymirt to induce disruption or formation of mirRNA binding site:

  dbSNP ID Variant Wobble Ancestral Allele miR ID Conservation miRSite Function context+
type base pair Allele Class score change
1.29E+08 rs200447778  SNP    Y    A            
 G hsa-miR-1238-3p 7 aaaagtGAGGAAA  C No Change
hsa-miR-670-3p 6 aaaagtGAGGAAA  C No Change
1.29E+08 rs181048497  SNP   N   C            
           
           
           
 G hsa-miR-1178-3p 1 aatgtcGTGAGCA  C -0.267
1.29E+08 rs35524866 SNP  Y  G            
         
         
  A hsa-miR-219a-5p  1 tcctgaACAATCA  C -0.096
hsa-miR-4445-5p  1 tcctgAACAATCA  C -0.228
hsa-miR-4782-3p  1 tcctgaACAATCA  C -0.096
hsa-miR-508-3p  1 tcctgaACAATCA  C -0.097
hsa-miR-6766-3p  1 tcctgaACAATCA  C -0.096
1.29E+08 rs200570465  SNP   N   A            
           
 C C hsa-miR-24-3p  1 CTGAGCCAtcacc  C -0.402
hsa-miR-4284  1 cTGAGCCAtcacc  C -0.163
1.29E+08 rs2070583  SNP   Y   A  A hsa-miR-6800-5p  2 gcaaTCACCTAtg  D -0.298
 G hsa-miR-8053  1 gcAATCGCCtatg  C -0.298
1.29E+08 rs149534345 SNP   Y   A            
 G  hsa-miR-4677-3p 15 CTCACAGccttgg   C -0.135
hsa-miR-7974 19 ctCACAGCCttgg   C -0.236
1.29E+08    rs14607 SNP   N   T  T  hsa-miR-4432  3 GAGTCTTgagact   D -0.177
hsa-miR-513c-5p  2 gagtCTTGAGAct   D -0.13
hsa-miR-514b-5p  2 gagtCTTGAGAct   D -0.148
  C hsa-miR-516a-5p  2 gagtCTCGAGAct   C -0.297
1.29E+08 rs185650723 SNP   N   C   C  hsa-miR-135a-5p 13 atttAGCCATAat   D -0.17
hsa-miR-135b-5p 13 atttAGCCATAat   D -0.17
hsa-miR-8074 11 atttaGCCATAAt   D -0.197
hsa-miR-889-5p 13 atttAGCCATAat   D -0.164
  T hsa-miR-6831-3p 12 atTTAGTCAtaat   C -0.131
1.29E+08 rs4645970  SNP   Y   A   A  hsa-miR-135a-5p 13 ttAGCCATAatgt   D -0.17
hsa-miR-135b-5p 13 ttAGCCATAatgt   D -0.17
hsa-miR-8074 11 ttaGCCATAAtgt   D -0.197
hsa-miR-889-5p 13 ttAGCCATAatgt   D -0.164
  G hsa-miR-323a-3p 14 ttagccGTAATGT   C -0.151
1.29E+08 rs143895359  SNP   N   A            
           
1.29E+08 rs190322311 SNP   Y   A            
  G  hsa-miR-1284   2 cctagTGTATAGt   C -0.152
hsa-miR-4704-5p   1 cCTAGTGTAtagt   C -0.386
hsa-miR-4789-5p   1 cctaGTGTATAgt   C -0.147

Table 5: shows the SNPs predicted by SNPs Function prediction in 5UTR.

SNP Allele Position Prediction Strand Forward Sequence Matrix Score Method   
rs4645946 G 2            + CGAGAAG SRp40 2.86 ESEfind
rs4645946  A 4            + CTCAAGA SF2ASF2 3.07 ESEfind
rs4645946  A 4            + CTCAAGA SF2ASF1 2.95  ESEfind   
rs4645946  A 5            + CCTCAAG SRp40 4.35  ESEfind
rs4645946  G 1            + GAGAAG NA NA  RESCUE-ESE
rs4645946  A 1            + AAGAAG NA  NA RESCUE-ESE
rs4645946  A 2            + CAAGAA NA   NA RESCUE-ESE
rs4645946  A 3            + TCAAGA NA NA RESCUE-ESE
REFERENCES

1. Hoffbrand AV, Pettit JE, Moss PAH. Essential haematology. 6th edition, Blackwell science Inc.2011.

2. Schmitz R, Ceribelli M, Pittaluga S, Wright G, Louis M. Staudt Oncogenic Mechanisms in Burkitt Lymphoma. Cold Spring Harb Perspect Med. 2014; 4.

3. Levens D. Disentangling the MYC web. Proc Natl Acad Sci U S A. 2002; 99: 5757-5759.

4. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet. 2008; 40: 43-50.

5. Dang CV. MYC on the path to cancer. Cell. 2012; 149: 22-35.

6. Cowling VH, Cole MD. The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding. Mol Cell Biol. 2007; 27: 2059-2073.

7. Grandori C, Roman NG, Zoe A. Edkins F, Ngouenet C, Denise A, et al. White c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nature Cell Biology. 2005; 7: 311-318.

8. Cole MD, McMahon SB. The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene. 1999; 18: 2916- 2924.

9. Boxer LM, Dang CV. Translocations involving c-myc and c-myc function. Oncogene. 2001 10; 20: 5595-5610. 

10. Archibald S. Perkins, Jonathan W. Friedberg. Burkitt Lymphoma in Adults hematology. 2008; 341-348.

11. Perkins AS, Friedberg JW. Burkitt lymphoma in adults. Hematology Am Soc Hematol Educ Program. 2008:341-348.

12. O’Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 2005; 435: 839-843.

13. Salghetti SE, Kim SY, Tansey WP. Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. Embo J. 1999; 18: 717-726.

14. Thomas LR, Tansey WP. Proteolytic control of the oncoprotein transcription factor Myc. Adv Cancer Res. 2011; 110: 77-106.

15. Adhikary S, Marinoni F, Hock A, Hulleman E, Popov N, Beier R, et al. The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell. 2005; 123: 409- 421. 

16. Popov N, Schülein C, Jaenicke LA, Eilers M. Ubiquitylation of the amino terminus of Myc by SCF (β-TrCP) antagonizes SCF (Fbw7)-mediated turnover. Nat Cell Biol. 2010; 12: 973-981.

17. Popov N, Wanzel M, Madiredjo M, Zhang D, Beijersbergen R, Bernards R , et al. The ubiquitin-specific protease USP28 is required for MYC stability. Nat Cell Biol. 2007; 9: 765-774.

18. Warde-Farley D, Donaldson SL,Comes O, Zuberi K, Badrawi R, Chao P, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. J. Nucleic Acids Res. 2010.

19. Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003; 31: 3812-3814.

20. Venselaar H, Te Beek TA, Kuipers RK, Hekkelman ML, Vriend G. Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinformatics. 2010; 11: 548.

21. González-Pérez A, López-Bigas N. Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am J Hum Genet. 2011; 88: 440-449.

22. Bava KA, Gromiha MM, Uedaira H, Kitajima K, Sarai A. ProTherm, version 4.0: thermodynamic database for proteins and mutants. Nucleic Acids Res. 2004; 32: 120-121.

23. Capriotti E, Fariselli P, Calabrese R, Casadio R. Predicting protein stability changes from sequences using support vector machines. Bioinformatic. 2005; 21: 54-58.

24. Venselaar H, Beek TA, Kuipers RK, Hekkelman ML, Vriend G. Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. J BMC bioinformatics. 2010; 11: 548.

25. Källberg M, Wang H, Wang S, Peng J, Wang Z, Lu H, et al. Template-based protein structure modeling using the RaptorX web server. Nat Protoc. 2012; 7: 1511-22.

26. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25: 1605-12.

27. Taylor JG, Tang DC, Savage SA, Leitman SF, Heller SI, Serjeant GR, et al. Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood. 2002; 100: 4303-4309.

28. Wang P, Dai M, Xuan W, McEachin RC, Jackson AU, Scott LJ, et al. SNP Function Portal: a web database for exploring the function implication of SNP alleles. Bioinformatics. 2006; 22: 523-529.

29. Noreen M, Murad S, Khan H. In Silico Analysis of SNPs in Coding Region of Human c-Myc Gene. Pakistan J. Zool. 2015; 47: 1305-1318.

Fadlalla Elshaikh AAE, Elmahdi Ahmed MT, Daf Alla TIM, Mogammed Elbasheer AS, Ahmed AA, et al. (2016) Computational Analysis of Single Nucleotide Polymorphism (Snps) In Human MYC Gene. J Bioinform, Genomics, Proteomics 1(3): 1011.

Received : 06 Sep 2016
Accepted : 22 Nov 2016
Published : 23 Nov 2016
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X